Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsInfectious Disease

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1229587

Cover Image

PUBLISHER: Transparency Market Research | PRODUCT CODE: 1229587

COVID-19 Diagnostics Market (Product: Instruments and Reagents & Kits; Test Type: Molecular Tests, Antigen Tests, and Antibody Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

PUBLISHED:
PAGES: 226 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5795
PDF (Multi-user License)
USD 8795
PDF (Corporate License)
USD 11795

Add to Cart

Description

Table of Contents

List of Tables

The report provides revenue of the global COVID-19 diagnostics market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global COVID-19 diagnostics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the COVID-19 diagnostics market.

The report delves into the competitive landscape of the global COVID-19 diagnostics market. Key players operating in the global COVID-19 diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global COVID-19 diagnostics market profiled in this report.

Show more
Product Code: TMRGL80305

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global COVID-19 Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global COVID-19 Diagnostics Market Analysis and Forecast, 2020-2031

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. COVID-19 Antigen Diagnostic Test Pipeline
  • 5.3. Insights on FDA Approved COVID-19 Home Diagnostic Test
  • 5.4. Regulatory Authorizations by Country for COVID-19 Diagnostic Tests

6. Global COVID-19 Diagnostics Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2020-2031
    • 6.3.1. Instruments
    • 6.3.2. Reagents & Kits
  • 6.4. Market Attractiveness Analysis, by Product

7. Global COVID-19 Diagnostics Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2031
    • 7.3.1. Molecular Tests
    • 7.3.2. Antigen Test
    • 7.3.3. Antibody (serology) Tests
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global COVID-19 Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2031
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. At-home Testing
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global COVID-19 Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America COVID-19 Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2020-2031
    • 10.2.1. Instruments
    • 10.2.2. Reagents & Kits
  • 10.3. Market Value Forecast, by Test Type, 2020-2031
    • 10.3.1. Molecular Tests
    • 10.3.2. Antigen Test
    • 10.3.3. Antibody (serology) Tests
  • 10.4. Market Value Forecast, by End-user, 2020-2031
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. At-home Testing
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Test Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe COVID-19 Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2020-2031
    • 11.2.1. Instruments
    • 11.2.2. Reagents & Kits
  • 11.3. Market Value Forecast, by Test Type, 2020-2031
    • 11.3.1. Molecular Tests
    • 11.3.2. Antigen Test
    • 11.3.3. Antibody (serology) Tests
  • 11.4. Market Value Forecast, by End-user, 2020-2031
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. At-home Testing
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Test Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific COVID-19 Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2020-2031
    • 12.2.1. Instruments
    • 12.2.2. Reagents & Kits
  • 12.3. Market Value Forecast, by Test Type, 2020-2031
    • 12.3.1. Molecular Tests
    • 12.3.2. Antigen Test
    • 12.3.3. Antibody (Serology) Tests
  • 12.4. Market Value Forecast, by End-user, 2020-2031
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. At-home Testing
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Test Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America COVID-19 Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2020-2031
    • 13.2.1. Instruments
    • 13.2.2. Reagents & Kits
  • 13.3. Market Value Forecast, by Test Type, 2020-2031
    • 13.3.1. Molecular Tests
    • 13.3.2. Antigen Test
    • 13.3.3. Antibody (serology) Tests
  • 13.4. Market Value Forecast, by End-user, 2020-2031
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. At-home Testing
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Test Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa COVID-19 Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2020-2031
    • 14.2.1. Instruments
    • 14.2.2. Reagents & Kits
  • 14.3. Market Value Forecast, by Test Type, 2020-2031
    • 14.3.1. Molecular Tests
    • 14.3.2. Antigen Test
    • 14.3.3. Antibody (serology) Tests
  • 14.4. Market Value Forecast, by End-user, 2020-2031
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. At-home Testing
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of MEA
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Test Type
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Becton, Dickinson and Company (BD)
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bio-Rad Laboratories, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Danaher Corporation (Cepheid)
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Hologic, Inc.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Laboratory Corporation of America Holdings
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. PerkinElmer, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Quest Diagnostics
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Thermo Fisher Scientific, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
Show more
Product Code: TMRGL80305

List of Tables

  • Table 01: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 02: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 03: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 04: Global COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Region, 2020-2031
  • Table 05: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country, 2020-2031
  • Table 06: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 07: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 08: North America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 09: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 10: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 11: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 12: Europe COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 13: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 14: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 15: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 16: Asia Pacific COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 17: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 18: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 19: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 20: Latin America COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031
  • Table 21: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2031
  • Table 22: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Product, 2020-2031
  • Table 23: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by Test Type, 2020-2031
  • Table 24: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2020-2031

List of Figures

  • Figure 01: Global COVID-19 Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031
  • Figure 02: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by Product, 2021
  • Figure 03: Global COVID-19 Diagnostics Market Value Share, by Product, 2021
  • Figure 04: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by Test Type, 2021
  • Figure 05: Global COVID-19 Diagnostics Market Value Share, by Test Type, 2021
  • Figure 06: Global COVID-19 Diagnostics Market Revenue (US$ Mn), by End-user, 2021
  • Figure 07: Global COVID-19 Diagnostics Market Value Share, by End-user, 2021
  • Figure 08: Global COVID-19 Diagnostics Market Value Share, by Region, 2021
  • Figure 09: Global COVID-19 Diagnostics Market Value (US$ Mn) Forecast, 2020-2031
  • Figure 10: Global COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 11: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 12: Global COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 13: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 14: Global COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 15: Global COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 16: Global COVID-19 Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 17: Global COVID-19 Diagnostics Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 18: North America COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 19: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Country, 2020-2031
  • Figure 20: North America COVID-19 Diagnostics Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 21: North America COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 22: North America COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 23: North America COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 24: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 25: North America COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 26:North America COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 27: Europe COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 28: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 29: Europe COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 30: Europe COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 31: Europe COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 32: Europe COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 33: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 34: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 35: Europe COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 36: Asia Pacific COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 37: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 38: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 39: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 40: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 41: Asia Pacific COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 42: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 43: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 44: Asia Pacific COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 45: Latin America COVID-19 Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 46: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 47: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 48: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 49: Latin America COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 50: Latin America COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 51: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 52: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 53: Latin America COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 54: Middle East & Africa COVID-19 Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2031
  • Figure 55: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020-2031
  • Figure 56: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 57: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
  • Figure 58: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 59: Middle East & Africa COVID-19 Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 60: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Product, 2022-2031
  • Figure 61: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 62: Middle East & Africa COVID-19 Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!